医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Chinese Dialysis Industry Discussed in New Huidian Research Report Now Available at MarketPublishers.com

2013年05月22日 AM01:40
このエントリーをはてなブックマークに追加


 

LONDON

The dialysis population is relatively small in China, but has been growing faster compared with that of Europe and the United States. In the next five years, in line with the expansion of medical insurance coverage and a hike in national income, the number of dialysis patients is poised for rapid growth.

In 2012, the country’s dialysis market was worth about CNY 12bn, with the values of hemodialysis and peritoneal sectors being estimated at nearly CNY10bn and CNY 2bn, respectively. Hemodialysis is the most common type of dialysis in China, with nearly 1,000 hospitals administering this treatment. Fresenius, Nikkiso, Baxter, Cambro, Asahi Kasei, among others, are foreign-funded enterprises lead the development of China’s dialysis market. Amid local enterprises, Weigao takes the lead in the field of hemodialysis machine, while Huaren Pharmaceutical is the leader in the peritoneal dialysis area.

New report “Research and Development Prospect of China Dialysis Market, 2013-2017” drawn up by Huidian Research provides an insightful analysis of the Chinese dialysis industry.

The study carries out a comprehensive analysis of the status quo of the dialysis industry in China and aboard, policy environment, existing problems and favorable factors of China’s dialysis industry. It gives a detailed overview of subdivided industries – dialyzer, dialysis machine and hemodialysis solutions; import and export of dialysis equipments; as well as looks into the business performance of the key overseas and domestic production enterprises. Furthermore, the research offers an in-depth discussion of the market prospects and future industry projections to 2017; concluding with a comprehensive review of investment opportunities and risks of the Chinese dialysis industry.

Report Details:

Title: Research and Development Prospect of China Dialysis Market, 2013-2017

Published: May, 2013

Pages: 72

Price: US$ 2,000.00

http://marketpublishers.com/report/life_sciences/healthcare/research-n-development-prospect-of-china-dialysis-market-2013-2017.html

More China Market Reports by Huidian Research Include:

More new reports by Huidian Research can be found at http://marketpublishers.com/members/huidian/info.html

CONTACT

The Market Publishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax:
+44 207 900 3970
ps@marketpublishers.com
MarketPublishers.com

同じカテゴリーの記事 

  • AriBio 获得欧洲药品管理局对AR1001治疗阿尔茨海默病3期临床试验(POLARIS-AD)的授权
  • AriBio Receives EMA Phase 3 Clinical Trial Authorisation for AR1001 in Treatment of Alzheimer’s Disease (POLARIS-AD)
  • ReNAgadeセラピューティクス、GanNA Bioと糖鎖生物学に対するコミットメントを継続
  • ReNAgade Therapeutics继续致力于GanNA Bio和糖生物学的研究
  • ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology